Switch to:
More From Other Websites
ATYR PHARMA INC Financials Nov 23 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
ATYR PHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Nov 21 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
aTyr Pharma (LIFE) Looks Good: Stock Adds 5.9% in Session Nov 18 2016
Atyr Pharma reports 3Q loss Nov 14 2016
Atyr Pharma reports 3Q loss Nov 14 2016
aTyr Pharma Announces Third Quarter 2016 Operating Results Nov 14 2016
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 14 2016
aTyr Pharma Announces Third Quarter 2016 Operating Results Nov 14 2016
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure Nov 07 2016
aTyr Pharma Receives Fast Track Designation (LIFE) Oct 26 2016
aTyr Receives FDA Fast Track Designation Oct 24 2016
aTyr Pharma Receives FDA Fast Track Designation for Resolaris™ to Treat Facioscapulohumeral... Oct 24 2016
aTyr Pharma Receives FDA Fast Track Designation for Resolaris™ to Treat Facioscapulohumeral... Oct 24 2016
Genovis signs license agreement with Life Technologies Corporation Oct 17 2016
BMO Sets $8 Target for Atyr Pharma (LIFE) Oct 10 2016
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events Oct 06 2016
aTyr Pharma Presents Additional Data for Resolaris™ Phase 1b/2 Trial in Adult Patients with... Oct 06 2016
Gershman of aTyr Pharma to Speak on Muscular Dystrophy (LIFE) Sep 29 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK